Literature DB >> 26897743

Is cardiac and hepatic iron status assessed by MRI T2* associated with left ventricular function in patients with idiopathic cardiomyopathy?

Yumiko Kanzaki1, Masako Yuki2, Ken-Ichiro Yamamura2, Yoshifumi Narumi2, Nobukazu Ishizaka3.   

Abstract

Excess accumulation of iron in the heart is known to aggravate cardiac function in some cases of genetic and acquired iron overload. We investigated the possible association between cardiac function and iron content in the heart and liver, estimated non-invasively by T2 star (T2*)-weighted magnetic resonance (MR) imaging among patients with cardiomyopathy. MR images were acquired on a 3.0 T MR imaging system using an 8-channel phased-array cardiac coil. Average T2* values of the heart were estimated at regions of interest that were located on short axis mid-ventricular slices positioned at the cardiac septum. In total, 82 patients were enrolled: 48 patients with dilated cardiomyopathy (DCM), 16 patients with hypertrophic cardiomyopathy (HCM), and 18 patients without apparent cardiovascular abnormalities. Cardiac T2* values were lower in the DCM group (median 18.6 ms) than in the HCM (22.0 ms) and control (21.4 ms) groups, although hepatic T2* values did not differ significantly across the groups. Among the whole population, the highest cardiac T2* tertile (≥21.2 ms) was significantly negatively associated with a low left ventricular ejection fraction (LVEF) of <50 %, and this association retained statistical significance after adjustment for sex, age, renal function, hemoglobin and hepatic T2*. Among DCM patients, both hemoglobin and cardiac T2* were selected as parameters that were, respectively, negatively and positively, associated with LVEF (P < 0.05). DCM patients with lower cardiac T2*, and thus higher iron content, were found to have lower LVEF. The possibility that cardiac iron overload may have a role in reducing the systolic cardiac function in DCM patients who do not have systemic iron overload requires further investigation in the future.

Entities:  

Keywords:  Cardiomyopathy; Hemoglobin; Iron; Magnetic resonance imaging; T2*

Mesh:

Substances:

Year:  2016        PMID: 26897743     DOI: 10.1007/s00380-016-0814-1

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  40 in total

1.  Comparison of myocardial and hepatic iron loading, assessed by MRI T2*, in patients with myelodysplastic syndromes, thalassaemia major and controls.

Authors:  Sophie Mavrogeni
Journal:  Blood Transfus       Date:  2011-12-21       Impact factor: 3.443

2.  Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study.

Authors:  Alan S Go; Jingrong Yang; Lynn M Ackerson; Krista Lepper; Sean Robbins; Barry M Massie; Michael G Shlipak
Journal:  Circulation       Date:  2006-06-05       Impact factor: 29.690

3.  MRI guided iron assessment and oral chelator use improve iron status in thalassemia major patients.

Authors:  Diana X Nichols-Vinueza; Matthew T White; Andrew J Powell; Puja Banka; Ellis J Neufeld
Journal:  Am J Hematol       Date:  2014-04-10       Impact factor: 10.047

4.  Multicenter validation of the magnetic resonance T2* technique for segmental and global quantification of myocardial iron.

Authors:  Anna Ramazzotti; Alessia Pepe; Vincenzo Positano; Giuseppe Rossi; Daniele De Marchi; Maria Gabriella Brizi; Antongiulio Luciani; Massimo Midiri; Giuseppina Sallustio; Gianluca Valeri; Vincenzo Caruso; Michele Centra; Paolo Cianciulli; Vincenzo De Sanctis; Aurelio Maggio; Massimo Lombardi
Journal:  J Magn Reson Imaging       Date:  2009-07       Impact factor: 4.813

5.  Cardiac iron overload assessed by T2* magnetic resonance imaging and cardiac function in regularly transfused myelodysplastic syndrome patients.

Authors:  Laurent Pascal; Odile Beyne-Rauzy; Sabine Brechignac; Sylvestre Marechaux; Dominique Vassilieff; Olivier Ernst; Céline Berthon; Emmanuel Gyan; Marie-Pierre Gourin; François Dreyfus; Pierre Fenaux; Christian Rose
Journal:  Br J Haematol       Date:  2013-05-09       Impact factor: 6.998

6.  T-type calcium channel as a portal of iron uptake into cardiomyocytes of beta-thalassemic mice.

Authors:  Sirinart Kumfu; Siriporn Chattipakorn; Somdet Srichairatanakool; Jongkolnee Settakorn; Suthat Fucharoen; Nipon Chattipakorn
Journal:  Eur J Haematol       Date:  2010-12-29       Impact factor: 2.997

7.  Association of anemia and renal dysfunction with in-hospital mortality among patients hospitalized for acute heart failure syndromes with preserved or reduced ejection fraction.

Authors:  Katsuya Kajimoto; Naoki Sato; Teruo Takano
Journal:  Eur Heart J Acute Cardiovasc Care       Date:  2016-09-22

8.  Myocardial and systemic iron depletion in heart failure implications for anemia accompanying heart failure.

Authors:  Micha T Maeder; Ouda Khammy; Cris dos Remedios; David M Kaye
Journal:  J Am Coll Cardiol       Date:  2011-07-26       Impact factor: 24.094

Review 9.  Cardiomyopathy associated with iron overload: how does iron enter myocytes and what are the implications for pharmacological therapy?

Authors:  Karn Wijarnpreecha; Sirinart Kumfu; Siriporn C Chattipakorn; Nipon Chattipakorn
Journal:  Hemoglobin       Date:  2015-01-09       Impact factor: 0.849

10.  Revised equations for estimated GFR from serum creatinine in Japan.

Authors:  Seiichi Matsuo; Enyu Imai; Masaru Horio; Yoshinari Yasuda; Kimio Tomita; Kosaku Nitta; Kunihiro Yamagata; Yasuhiko Tomino; Hitoshi Yokoyama; Akira Hishida
Journal:  Am J Kidney Dis       Date:  2009-04-01       Impact factor: 8.860

View more
  3 in total

1.  Cardiovascular magnetic resonance native T2 and T2* quantitative values for cardiomyopathies and heart transplantations: a systematic review and meta-analysis.

Authors:  G J H Snel; M van den Boomen; L M Hernandez; C T Nguyen; D E Sosnovik; B K Velthuis; R H J A Slart; R J H Borra; N H J Prakken
Journal:  J Cardiovasc Magn Reson       Date:  2020-05-11       Impact factor: 5.364

Review 2.  Cardiac T2 * mapping: Techniques and clinical applications.

Authors:  Pandji Triadyaksa; Matthijs Oudkerk; Paul E Sijens
Journal:  J Magn Reson Imaging       Date:  2019-12-14       Impact factor: 4.813

3.  Cardiac MRI T2* in Liver Transplant Candidates: Application and Performance of a Novel Imaging Technique to Identify Patients at Risk for Poor Posttransplant Cardiac Outcomes.

Authors:  Sara M Lewin; Kimberly Kallianos; M Ilan Nevah; Susan Zhao; Oren K Fix; Gabriel C Brooks; Teresa De Marco; Atif N Qasim; Karen G Ordovas; Neil Mehta
Journal:  Transplant Direct       Date:  2018-06-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.